Hidden tumor antigens discovered, potentially expanding colorectal cancer immunotherapy

A new study published in *Molecular & Cellular Proteomics* challenges previous assumptions, revealing that treatment-resistant colorectal tumors harbor tumor antigens capable of triggering immune recognition. This finding could lead to new immunotherapy approaches for colorectal cancers that previously responded poorly to treatment.